Searched for
ASTRAZENECA SHARE PRICE
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- Ahead of Market: 10 things that will decide stock market action on MondayIndian stock markets experienced sharp cuts on Thursday, with Nifty and Sensex declining due to rising oil prices and a falling rupee. Sell...
- UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weighLondon’s FTSE 100 edged lower as losses in energy majors and AstraZeneca weighed on the index amid thin holiday trading. Weak crude prices ...
- Global Markets | European markets dip as investors eye earnings, Iran conflict continues to weighEuropean shares dipped on Wednesday, as investors turned their focus to a packed day of corporate earnings, while a continuing U.S.-Iran im...
- Banquets and billions: How AstraZeneca sealed a US medicine deal with TrumpAstraZeneca CEO Pascal Soriot met with U.S. President Donald Trump to finalize a medicine deal. This agreement will lower drug prices for m...
- AstraZeneca targets 2024 growth but mixed views hit sharesIn almost a decade since AstraZeneca fended off a takeover by U.S. rival Pfizer, CEO Pascal Soriot has rebuilt the Anglo-Swedish drugmaker'...
- AstraZeneca India Q1 results: Net profit declines 45% to Rs 10 crRevenue from operations stood at Rs 175.40 crore for the quarter under consideration. It was Rs 193.57 crore for the same period a year ago...
- AstraZeneca to acquire Alexion in $39 billion dealAlexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share.
- Stock market news: AstraZeneca Pharma shares tank nearly 6%A total of 21,919 shares changed hands on the counter till 11:12AM (IST).
- AstraZeneca Pharma India gets DCGI nod to market diabetes drugThe product is indicated as an adjunct therapy to diet and exercise to improve glycemic control in adults with type 2 diabetes, AstraZeneca...
- Under Sebi lens, Elliott offloads 6% in AstraZenecaSebi’s deadline to investigate dealings of the Elliott Group with regard to the de-listing of Astra-Zeneca ended on March 11.
- AstraZeneca rejects 55 pounds/share Pfizer offerBritain's AstraZeneca on Monday rejected a sweetened 55-pounds-a-share offer from Pfizer.
- AstraZeneca rallies 15%, hits 52-week high ahead of board meet; up 50% in a monthAfter rallying 20 per cent in trade yesterday, AstraZeneca Pharma put up a strong show today ahead of the company's board meet on Wednesday.
- AstraZeneca jumps 20 per cent on delisting planAstraZeneca’s India unit has revived its plan of delisting the co from the stock markets, an announcement that sent company’s shares soarin...
- AstraZeneca Pharma OFS begins at Rs 490/share; stock tanks 17%The OFS is being launched to meet SEBI's norm on minimum 25 pc public shareholding for private sector listed companies.
- AstraZeneca Pharma promoter to sell stake in Indian armAstraZeneca India today said its promoter AstraZeneca Pharmaceuticals AB Sweden plans to offload around 37 lakh shares through offer for sa...
- AstraZeneca planning to delist Indian subsidiary; likely to appoint Merrill Lynch as manager for delistingAstraZeneca, the world's seventh largest drug maker by sales, is planning to delist its Indian subsidiary, said two people with knowledge o...
- 25pc public holding norm has AstraZeneca, Sulzer delistingThe domestic arms of two multinational companies, the drug maker AstraZeneca and process engineering major Sulzer, plan to delist from the ...
- AstraZeneca Pharma to delist from India; shares jump 20 pcAstraZeneca Pharma India today said it will de-list itself from domestic stock exchanges, fueling a jump of 20 per cent in its stock price ...
Load More
